The effects of thymoquinone and cytozine arabinoside on apoptosis and cell proliferation in acute myeloide leukemia
- 11 October 2022
- journal article
- Published by Peertechz Publications Private Limited in Global Journal of Cancer Therapy
- Vol. 8 (1), 040-045
- https://doi.org/10.17352/2581-5407.000047
Abstract
Purpose: The aim of this study was to investigate the effects of a chemotherapeutic agent Cytosine Arabinoside (Ara-C) and a natural anticancer agent of Thymoquinone (TQ) on apoptosis and cell proliferation of AML cell lines (Kasumi-6) both alone and in combined form. Material and method: Kasumi-6 AML cells were treated with three different doses of Ara-C (0.1, 0.5 and 1 µmol) and TQ (25, 50 and 100 µM) for 48 and 72 hours incubations. After Annexin V and Propidium Iodide (PI) staining, apoptosis, viability, and cell proliferation were evaluated for each group in flow cytometry. Results: As a result, AML cell lines showed a statistically significant difference in a single treatment of the active substances. Their combined treatment showed an increase in apoptosis and a decrease in viability in both groups at 48 and 72 hours incubation times (p < 0.001). In each group, it was observed that apoptosis was increased and viability was decreased and consequently cell proliferation was suppressed. Conclusion: Ara-C was used for the first time in this study with TQ in AML. It was determined that the combined use of TQ and Ara-C did not have a synergistic effect on apoptosis.Keywords
This publication has 30 references indexed in Scilit:
- Thymoquinone Inhibits Tumor Growth and Induces Apoptosis in a Breast Cancer Xenograft Mouse Model: The Role of p38 MAPK and ROSPLOS ONE, 2013
- Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivoJournal of Experimental & Clinical Cancer Research, 2010
- The roles of bioactive sphingolipids in resveratrol-induced apoptosis in HL60 acute myeloid leukemia cellsZeitschrift für Krebsforschung und Klinische Onkologie, 2010
- Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signalingApoptosis, 2009
- Antitumor Activity of Gemcitabine and Oxaliplatin Is Augmented by Thymoquinone in Pancreatic CancerCancer Research, 2009
- Selective anticancer strategies via intervention of the death pathways relevant to cell transformationCell Death & Differentiation, 2008
- Androgen Receptor– and E2F-1–Targeted Thymoquinone Therapy for Hormone-Refractory Prostate CancerCancer Research, 2007
- Thymoquinone induces apoptosis through activation of caspase‐8 and mitochondrial events in p53‐null myeloblastic leukemia HL‐60 cellsInternational Journal of Cancer, 2005
- The role of pharmacokinetic and pharmacodynamic studies in the planning of protocols for the treatment of childhood cancerCancer Treatment Reviews, 1999
- Apoptosis in brain-specific autoimmune diseaseCurrent Opinion in Immunology, 1995